Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History

Nymox Pharmaceutical Corporation NYMX

Sector: Healthcare | Sub-Sector: Biotechnology

Nymox Pharmaceutical Corp along with its subsidiaries is a biopharmaceutical corporation, engaged in research and development of diagnostics and drugs for brain disorders and diseases of the aged with an emphasis on Alzheimer's disease.
Price: $5.040 | Change: +$0.140 | %Change: +2.86%
Volume: 33,849 | Day High/Low: 5.05/4.85 | 52 Week High/Low: 8.19/4.40

Snapshot

Last Traded: July 28, 2014 07:48 Transaction Volume: 33,849
Open: $5.040 Previous Close: $4.90
Bid: $4.98 Ask: $5.08
Bid Size: 100 Ask Size: 100
Market Cap: $176.2m Shares Out: 35.0m
PE Ratio: N/A Dividend Yield: N/A
Scale: 1d 5d 3m 6m 1y 2y 5y
Type: Line Area OHLC

Advanced Charts

Latest Bullboard Posts

  • Good things coming

    0 stars

    The stock had a strong run this past week on the heels of the 7th annual Singular Research Conference. I'm looking for a possible buyout...

    1.5 stars


  • NX-1207 Outlook

    0 stars

    Is anyone out there following this stock? Their phase 3 trials for NX-1207 appear to be getting favourable reviews  for the treatment of...

    1.5 stars


  • breakout

    0 stars

    I think NYMX is getting ready for a breakout. By early 2010 we should be expecting  FDA marketing approval for NY-1207......approx 3...

    1.5 stars


  • **Contract news**

    0 stars

    They finally got the big contract and no insider buying leading up to news. NEWS RELEASE TRANSMITTED BY CCNMatthews FOR...

    3 stars


  • more news

    0 stars

    these anbody know more about this company

    0 stars